CONFERENCE COVERAGE SERIES
Human Amyloid Imaging 2012
Miami, FL, U.S.A.
12 – 13 January 2012
News Focus: 2012 Human Amyloid Imaging Conference
When 225 researchers convened to exchange the latest on β amyloid positron emission tomography (PET) on 12-13 January 2012, there was a palpable sense of urgency...
Miami: Amyloid PET in the Clinic: What Are the Issues?
The first amyloid imaging ligand that used Fluorine 18, florbetapir F18 (Amyvid™), is under regulatory review in the U.S. and Europe...
Miami: Scan and Tell? Amyloid Imaging Confronts Disclosure Dilemma
Thanks to amyloid-binding radiotracers and PET, research clinicians can now peer inside the living brain to see senile plaques that were once evident only at autopsy...
Miami: Can the Naked Eye Tell When a Scan Is Positive?
For amyloid imaging to become widely useful, a nuclear medicine physician should be able to look at a person’s scan and know if the scan is positive or negative...
Miami: When Does Amyloid Deposition Start in Familial Alzheimer’s?
Three speakers presented data on brain amyloid deposition in presymptomatic carriers of deterministic AD mutations starting as early as their young twenties...
Miami: Age and Amyloid—What Has ApoE Got to Do With It?
At the Human Amyloid Imaging Conference, several labs presented new data on the connection between ApoE and amyloid deposition in preclinical AD and aging...
Miami: Longitudinal Amyloid PET Data Start Converging
By and large, researchers' studies appear to support the notion that amyloid deposition heralds future cognitive decline...
Miami: Diagnosis and Amyloid Scan Can Be at Odds
On the clinical application of amyloid imaging and other biomarkers, scientists are confronting mismatches that leave them puzzled for the time being...
Miami: Scientists Angle for Way to Image Tangle
The last two talks at HAI were about efforts to develop a PET agent that will visualize the other pathologic lesion as defined by Alois Alzheimer...